Kornitzer Capital Management Inc Abbott Laboratories Transaction History

Kornitzer Capital Management Inc

$5.1 Billion
Q2 2024

A detailed history of Kornitzer Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 378,955 shares of ABT stock, worth $42.6 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

378,955

Previous 375,621 0.89%

Holding current value

$42.6 Million

Previous $42.7 Million 7.77%

% of portfolio

0.77%

Previous 0.81%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $335,833 - $374,874	3,334 Added 0.89%	378,955 $39.4 Million
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $3.09 Million - $3.42 Million	28,253 Added 8.13%	375,621 $42.7 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $4.46 Million - $5.46 Million	-49,483 Reduced 12.47%	347,368 $38.2 Million
Q3 2023 Oct 31, 2023	BUY	$95.53 - $114.62 $9.18 Million - $11 Million	96,052 Added 31.93%	396,851 $38.4 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $110,656 - $123,294	-1,098 Reduced 0.36%	300,799 $32.8 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $166,502 - $195,983	-1,719 Reduced 0.57%	301,897 $30.6 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $208,466 - $244,563	-2,193 Reduced 0.72%	303,616 $33.3 Million
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $966,632 - $1.12 Million	-9,990 Reduced 3.16%	305,809 $29.6 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $829,420 - $1 Million	8,126 Added 2.64%	315,799 $34.3 Million
Q1 2022 Apr 27, 2022	SELL	$114.02 - $139.04 $3.53 Million - $4.31 Million	-30,984 Reduced 9.15%	307,673 $36.4 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $1.28 Million - $1.56 Million	-11,051 Reduced 3.16%	338,657 $47.7 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $28,231 - $31,232	-242 Reduced 0.07%	349,708 $41.3 Million
Q2 2021 Jul 30, 2021	SELL	$105.79 - $124.53 $655,898 - $772,086	-6,200 Reduced 1.74%	349,950 $40.6 Million
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $1.23 Million - $1.45 Million	-11,342 Reduced 3.09%	356,150 $42.7 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $663,600 - $723,134	-6,320 Reduced 1.69%	367,492 $40.2 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $3.68 Million - $4.47 Million	-40,175 Reduced 9.7%	373,812 $40.7 Million
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $2.89 Million - $3.69 Million	-37,690 Reduced 8.34%	413,987 $37.9 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $589,314 - $861,738	-9,381 Reduced 2.03%	451,677 $35.6 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $2.51 Million - $2.8 Million	-32,013 Reduced 6.49%	461,058 $40 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $1.84 Million - $2 Million	-22,509 Reduced 4.37%	493,071 $41.3 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $667,435 - $778,430	-9,158 Reduced 1.75%	515,580 $43.4 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $322,491 - $389,892	-4,870 Reduced 0.92%	524,738 $41.9 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $370,741 - $419,996	-5,655 Reduced 1.06%	529,608 $38.3 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $436,311 - $526,358	7,175 Added 1.36%	535,263 $39.3 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $237,188 - $261,784	-4,120 Reduced 0.77%	528,088 $32.2 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $1.09 Million - $1.24 Million	-19,420 Reduced 3.52%	532,208 $31.9 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $2.57 Million - $2.75 Million	-47,793 Reduced 7.97%	551,628 $31.5 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $28.8 Million - $32.2 Million	599,421	599,421 $32 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Abbott Laboratories Transaction History